Roche comes out against allowing takeover of drug manufacturer Catalent
The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent by ...
emjreviews.com8d
Boehringer pledges $5m to WHO Foundation mental health initiative
Find out how this could enhance access to quality healthcare, with an emphasis on mental health services for vulnerable populations.
The Redstone Rocket8d
Airdropped vaccine combats rabies in wildlife
Rocket City residents are used to seeing low-flying helicopters and planes in the surrounding skies, but beginning Oct. 12 those aircraft won’t be coming from Redstone Arsenal. Instead, the U.S.
Law15d
GlaxoSmithKline Settles Most Zantac Lawsuits for $2.2B
"We continue to pursue claims against Boehringer Ingelheim for its wrongdoing in exposing millions of people to a known carcinogen for over a decade. Our fight against Boehringer Ingelheim ...
Pharmaceutical Technology15d
Anima Biotech’s machine learning programme ‘reveals new mRNA drug targets’
The company employs machine learning to uncover disease mechanisms at the mRNA level and to identify therapeutic candidates.
The Korea Bizwire16d
Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide
The U.S. FDA Breakthrough Therapy designation is for the treatment of adults with non-cirrhotic metabolic ...
Boehringer Ingelheim: Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide
The U.S. FDA Breakthrough Therapy designation is for the treatment of adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) and moderate or advanced fibrosis, based on surv ...
US FDA approves Elanco's treatment for parasitic infections in dogs
The U.S. Food and Drug Administration has approved Elanco Animal Health's oral drug to protect dogs against six parasitic ...
Mena FN21d
Enara Bio Raises $32.5 Million Series B Financing To Advance First-In-Class Pipeline Of TCR-Based Immunotherapies Targeting Novel Dark Antigens®
Our partner, Boehringer Ingelheim, is combining multiple Dark Antigens to create ... corporate venture capital fund of science and technology company Merck. From its headquarters in the Netherlands ...
Yahoo22d
GM is leaving its famed headquarters — but the building is already mostly empty
GM is moving its corporate headquarters across town to a building with a much smaller footprint, for obvious reasons. The automaker has confirmed that it does not currently have any plans to sell ...